Valeant's harsh words on ex-executives may play into govt probes
WASHINGTON/NEW YORK, March 21 (Reuters) - A move by Valeant Pharmaceuticals International Inc to single out two former top executives over its accounting problems is likely a bid to win leniency with...
No comments:
Post a Comment